TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 205 participants.

Also called NCT04570228

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 205 participants (planned count) (from the registry)
Sponsor
SoniVie Inc. (from the registry)
Registry
  • NCT NCT04570228
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04570228. Randomized; quadruple masking; primary purpose treatment. Start 2023-01-01 (anticipated); primary completion 2023-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study
Condition
Pulmonary Arterial Hypertension
Intervention (Device)
Pulmonary artery denervation
Intervention (Device)
Sham procedure
Lead sponsor
SoniVie Inc. (class: industry)

Record details

Record id
cardio:ct-nct04570228
Content hash
686be71d9659ecab6ca7021a5133db91e3eb5a9d463b7df108f12b981083f1a9